These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27856487)

  • 41. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Neumann FJ; Mehilli J; Frerker C; Richardt D; Landt M; Jose J; Toelg R; Kuck KH; Massberg S; Robinson DR; El-Mawardy M; Richardt G;
    J Am Coll Cardiol; 2015 Aug; 66(7):791-800. PubMed ID: 26271061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience.
    Ruparelia N; Latib A; Kawamoto H; Buzzatti N; Giannini F; Figini F; Mangieri A; Regazzoli D; Stella S; Sticchi A; Tanaka A; Ancona M; Agricola E; Monaco F; Spagnolo P; Chieffo A; Montorfano M; Alfieri O; Colombo A
    J Invasive Cardiol; 2016 May; 28(5):210-6. PubMed ID: 27145054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
    Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
    Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
    Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of Current-Generation Transfemoral Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Replacement.
    Habertheuer A; Gleason TG; Kilic A; Schindler J; Kliner D; Bianco V; Aranda-Michel E; Brown JA; Toma C; Muluktula S; Sultan I
    Ann Thorac Surg; 2021 Jun; 111(6):1968-1974. PubMed ID: 33045207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.
    Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M
    BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study.
    Corcione N; Morello A; Ferraro P; Cimmino M; Testa L; Petronio AS; Iadanza A; Bartorelli AL; Berti S; Regazzoli D; Romagnoli E; Spaccarotella C; Tespili M; Pepe M; Frati G; Biondi-Zoccai G; Giordano A;
    J Invasive Cardiol; 2021 May; 33(5):E320-E329. PubMed ID: 33739300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of third generation balloon-expandable Edwards Sapien 3 versus self-expandable Evolut R in transcatheter aortic valve implantation: a meta-analysis.
    Li YM; Tsauo JY; Liao YB; Zhao ZG; Chen M
    Ann Palliat Med; 2020 May; 9(3):700-708. PubMed ID: 32312063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the Edwards SAPIEN S3 Versus Medtronic Evolut-R Devices for Transcatheter Aortic Valve Implantation.
    Ben-Shoshan J; Konigstein M; Zahler D; Margolis G; Chorin E; Steinvil A; Arbel Y; Aviram G; Granot Y; Barkagan M; Keren G; Halkin A; Banai S; Finkelstein A
    Am J Cardiol; 2017 Jan; 119(2):302-307. PubMed ID: 28029363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
    Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
    Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
    Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transaortic transcatheter aortic valve implantation: experience from the Kiel study.
    Petzina R; Lutter G; Wolf C; Kühl C; Freitag-Wolf S; Panholzer B; Bramlage P; Frey N; Cremer J; Frank D
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):55-62. PubMed ID: 27600910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
    Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
    JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of the left ventricular outflow tract in the need for pacemaker implantation after transcatheter aortic valve replacement.
    Rodríguez-Olivares R; van Gils L; El Faquir N; Rahhab Z; Di Martino LF; van Weenen S; de Vries J; Galema TW; Geleijnse ML; Budde RP; Boersma E; de Jaegere PP; Van Mieghem NM
    Int J Cardiol; 2016 Aug; 216():9-15. PubMed ID: 27135150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
    Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
    Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
    J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.